DGAP-News: Nitinol Compression Anastomosis at Major French Surgical Meetings
(firmenpresse) - novoGI Inc.
29.04.2013 19:09
---------------------------------------------------------------------------
Enthusiastic Response to Clinical Sessions and Broadcast of Live Surgery
ATLANTA, 2013-04-29 19:09 CEST (GLOBE NEWSWIRE) --
novoGI Inc. today announced that its nitinol compression anastomosis technology
and novoGI(tm) ColonRing device were the focus of several scientific sessions at
recent gastrointestinal (GI) surgery meetings in France, the 16th Journees de
Chirurgie Digestive held in Bordeaux and the Journees de Chirurgie Digestive de
Beaujon in Paris.
Sessions by leading colorectal surgeons focused on recently published data for
successful outcomes for novoGI(tm) ColonRing in terms of low leak rates of 1.9% -
4% and healing processes for low anterior resection (LAR) procedures, training
methods, and ease of use for the surgical technique.
Prof Eric Rullier, MD (University Hospital, Bordeaux, France) led the session
novoGI Symposium Anastome colorectale par compression. During the same podium
session, Prof Paul-Antoine Lehur, MD (CHU de Nantes, Nantes, France) presented
the World Congress of Compression Anastomosis (WCCA), its organization and
goals, focusing on training methods. At the Paris meeting, Prof Yves Panis, MD,
PhD (Beaujon Hospital, Clichy, France) demonstrated the surgical technique
using the novoGI(tm) ColonRing compression anastomosis device in an LAR procedure
which was broadcast live to participants.
'We are very excited about the enthusiastic response to novoGI's compression
anastomosis technology - the clinical results and the actual surgical technique
- presented at these scientific meetings as well as last month's annual French
congress of 4,000 gastroenterologists, Journees Francophones
d'Hepato-gastroeneterologie et d'Oncologies Digestive (JFHOD), which included
4,000 medical professionals,' commented Jean-Paul Durand, novoGI Corporate Vice
President and General Manager for Europe.
'The success of recent events in France demonstrates novoGI's growing global
presence,' novoGI President and Chief Executive Officer, Gavriel D. Meron
noted. 'As we progress through this week's sessions of the American Society of
Colon&Rectal Surgeons (ASCRS) 2013 Annual Meeting in Phoenix, Arizona, we
look forward to next week's scientific symposium on novoGI's nitinol
compression anastomosis in Munich at the regional German conference of 8,000
surgeons.'
About novoGI
novoGI is focused on providing an expanding range of solutions for GI disease
management through a globally branded, high quality, market driven company. The
US headquarters are in Atlanta, Georgia; research, development and
manufacturing facilities in Netanya, Israel; and its European headquarters are
near Paris, France. The company's website is www.novoGI.com.
NOVOGI, the NOVOGI logo, the GI logo, and DEFINING THE FUTURE are trademarks
and/or registered trademarks of novoGI Inc.
For further information contact:
marcom(at)novoGI.com
www.novoGI.com
News Source: NASDAQ OMX
29.04.2013 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: novoGI Inc.
Israel
Phone:
Fax:
E-mail:
Internet:
ISIN: US9902064198
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.04.2013 - 19:09 Uhr
Sprache: Deutsch
News-ID 253982
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 285 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Nitinol Compression Anastomosis at Major French Surgical Meetings"
steht unter der journalistisch-redaktionellen Verantwortung von
novoGI Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
